期刊文献+

氯沙坦和螺内酯及联合应用对心肌梗死大鼠早期新生血管的影响 被引量:2

Effects of losartan,spironolactone and combination therapy on angiogenesis at early period after myocardial infarction in rats
下载PDF
导出
摘要 目的观察氯沙坦、螺内酯及二者合用对急性心肌梗死早期毛细血管的影响。方法建立大鼠的心肌梗死模型,早期应用醛固酮受体拮抗剂螺内酯20 mg.kg-1.d-1,血管紧张素-ⅡATI受体拮抗剂氯沙坦10 mg.kg-1.d-1及二者合用进行干预与心肌梗死组比较,观察心肌梗死后3 d,7 d梗死周围区毛细血管密度的变化。结果梗死周围区毛细血管密度在心肌梗死后3 d和7 d用药组均高于心肌梗死组(P<0.01)。结论氯沙坦、螺内酯及其联合应用有助于改善急性心肌梗死后侧支循环。 Objective To investigate the effects of losartan,spironolactone and combination therapy on capillaries at early period after myocardial infarction in rats.Methods After the establishment of the myocardial infarction models,the rats were administrated with aldosterone receptor antagonist-spironolactone 20 mg·kg-1·d-1,angiotensin-Ⅱ ATI receptor antagonist-losartan 10mg·kg-1·d-1at early period,then,combined appilication of the two drugs to intervent the myocardial infarction,and the therapeutic effects were observed and compared between the two groups.The changes of capillary density around the region of myocardial infarction on the 3rd and 7th day after myocardial infarction were observed.Results The capillary density around the region of myocardial infarction on the 3rd and 7th day after myocardial infarction in administration group was significantly higher than that of myocardial infarction group(P0.01).Conclusion The losartan,spironolactone alone and combination appilication of the two drugs can contribute to improving the collateral circulation after acute myocardial infarction in rats.
出处 《河北医药》 CAS 2011年第10期1455-1457,共3页 Hebei Medical Journal
关键词 氯沙坦 螺内酯 心肌梗死 毛细血管密度 losartan spironolactone acute myocardial infarction capillary density
  • 相关文献

参考文献7

  • 1Zannad F, Alia F, Dousset B, et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone thera- py in patients with congestive heart failure : insights from the randomized aldaetone evaluation study (RALES). Rales Investigators. Circulation, 2000.102:2700-2706.
  • 2Pitt B, Ruilope L, Bakris G, et al. Risk/benefit analysis of hyperkalemia in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Eur J Heart Fail Suppl,2004,3 : 116.
  • 3Shyam Bhakta and Mark E Dunlap. Angiotensin-receptor blockers in heart failure :evidence from the CHARM trial. Cleveland Clinic Journal of Medicine,2004,71 : 665 -673.
  • 4Henry K, Peter C, Csaba F, et al. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure:results from Val-He FT. Eur J Heart Fail,2004,6:937-945.
  • 5Michel F, Ambroisine ML, Dufiez M, et al. Aldosterone Enhances Ischemia-Induced Neovasculafization Through Angiotensin ]I -Dependent Pathway. Circulation ,2004, 109 : 1933-1937.
  • 6Hayashi M ,Tsutamoto T, Wada A, et al. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction : extracting aldostcrone through the heart promotes ventricular remodeling after acute myocardial infarction. J Am Coil Cardiol,2001,38 :1375-1382.
  • 7Munk VC, Miguel LS, Petrimpol M, et al. Angiotensin II Induces Anglogenesis in the Hypoxic Adult Mouse Heart In Vitro Through an AT2-B2 Receptor Pathway. Hypertension ,2007,49 : 1178-1185.

同被引文献21

  • 1Dong S, Cheng Y, Yang J, et al. MicroRNA Expression Signature and the Rolerof MicroRNA-21 in the Early Phase of Acute Myocardial Infarction. J Biol chem,2009 ,284 :29514-29525.
  • 2Patel NS, Sharpies EJ, Cuzzocrrea S, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusiou in the mouse kidney in vivo. Kidney Int,2004 ,66 :983-989.
  • 3Calvillo L, Latini R, Kajstura J, et al. Recombinant human erythropoietin pretects the myocardium from ischemia-reperfusion injury and promotes beneficial renmodeling. Proc Natl Acad Sci USA ,2003,100:4802-4806.
  • 4Danial NN, Korsmeyer SJ. Cell death: Critical control points. C cell, 2004,116:205-219.
  • 5Vincenti Y, Cassano C, Rocchi M, et al. Assignment of the vascuar endo- thelial growth factor gene to human chromosome 6p21.3. Circulation, 1996,93 : 1493-1495.
  • 6Yockman JW, Choi D, Whitten MG, et al. Polymeric gene delivery of is- chemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct. Gene Therapy,2009,16 : 127-135.
  • 7Ruixing Y, Jiaquan L, JIE C, et al. Intravenous administration of vascular endothelial growth factor improves caediac performance and inhibits car- diomvoevte aooptosis. Growth Factors ,2006,24:209-217.
  • 8陈志媛,周国胜,薛鸿群,牛宝松,狄长春,陈亚君,李清萍.急性心肌梗死患者肾素-血管紧张素Ⅱ-醛固酮活性变化[J].中国现代医生,2012,50(5):148-149. 被引量:4
  • 9谢晓春,芦炳蒋,张丽娜.螺内酯联合美托洛尔对急性心肌梗死急诊介入治疗后晚期左心室重构的影响[J].中国心血管病研究,2012,10(5):350-354. 被引量:1
  • 10黄炫生,张励庭,刘卫其,袁勇,吴颖,张劲.血清醛固酮和超敏C反应蛋白水平与急性心肌梗死接受急诊冠脉介入术患者预后的关系[J].中国实验诊断学,2012,16(6):1086-1088. 被引量:3

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部